Osaic Holdings’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-229
Closed -$98 7745
2024
Q3
$98 Hold
229
﹤0.01% 7249
2024
Q2
$144 Sell
229
-401
-64% -$408 ﹤0.01% 7203
2024
Q1
$1.11K Hold
630
﹤0.01% 6655
2023
Q4
$1.19K Buy
630
+4
+0.6% +$16 ﹤0.01% 6696
2023
Q3
$5.35K Sell
626
-17
-3% -$149 ﹤0.01% 6245
2023
Q2
$5.2K Hold
643
﹤0.01% 6287
2023
Q1
$3.76K Hold
643
﹤0.01% 6473
2022
Q4
$3K Sell
643
-34
-5% -$160 ﹤0.01% 6556
2022
Q3
$4K Sell
677
-382
-36% -$7.28K ﹤0.01% 6539
2022
Q2
$60K Buy
1,059
+8
+0.8% +$437 ﹤0.01% 4822
2022
Q1
$68K Buy
1,051
+346
+49% +$17.6K ﹤0.01% 4868
2021
Q4
$49K Hold
705
﹤0.01% 5172
2021
Q3
$50K Hold
705
﹤0.01% 5112
2021
Q2
$58K Sell
705
-262
-27% -$19.9K ﹤0.01% 4940
2021
Q1
$67K Sell
967
-196
-17% -$15.3K ﹤0.01% 4665
2020
Q4
$77K Sell
1,163
-65
-5% -$3.11K ﹤0.01% 4239
2020
Q3
$53K Sell
1,228
-233
-16% -$10.3K ﹤0.01% 4258
2020
Q2
$65K Sell
1,461
-4
-0.3% -$180 ﹤0.01% 4003
2020
Q1
$69K Buy
+1,465
New +$69K ﹤0.01% 3744

Osaic Holdings's NTBL Position: Q4 2024 in Review

Osaic Holdings sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q4 2024, closing a stake of 229 shares — an estimated $98 sold.

Osaic Holdings first reported a position in NTBL in Q1 2020 and held it in 19 quarters. The position peaked at $77K in Q4 2020. 0 funds tracked by Wall St. Rank hold NTBL as of Q4 2024.

  • Osaic Holdings reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 229 Notable Labs, Ltd. Ordinary Shares shares in Q4 2024, an estimated $98.
  • Osaic Holdings first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2020 and held it in 19 quarters.
  • Osaic Holdings's Notable Labs, Ltd. Ordinary Shares position peaked at $77K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.